Response

Journal of Bioethical Inquiry

Volumn 7, Issue 4, 2010, Pages 385-386

  Partridge, Brad ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649905765     PISSN: 11767529     EISSN: 18724353     Source Type: Journal    
DOI: 10.1007/s11673-010-9253-3     Document Type: Letter

References (5)

1. Finnoff, J. T., G. P. Chimes, and T. H. Murray. 2010. Performance enhancing drugs. Physical Medicine and Rehabilitation 2(4): 285-293.
2. Ford, B. D. 2010. Landis admits doping, accuses Lancehttp://sports. espn. go. com/oly/cycling/news/story?id=5203604& campaign=rss& source=ESPNHeadlines. May 21.
3. Forlini, C., and E. Racine. 2009. Autonomy and coercion in academic "cognitive enhancement" using methylphenidate: Perspectives of key stakeholders. Neuroethics 2: 163-177.
4. Greely, H., B. Sahakian, J. Harris, R. C. Kessler, M. Gazzaniga, P. Campbell, and M. J. Farah. 2008. Towards responsible use of cognitive-enhancing drugs by the healthy. Nature 456: 702-5.
5. Larriviere, D., M. A. Williams, M. Rizzo, and R. J. Bonnie. 2009. Responding to requests from adult patients for neuroenhancements: Guidance of the Ethics, Law and Humanities Committee. Neurology 73: 1406-12.